Cargando…

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME

This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being...

Descripción completa

Detalles Bibliográficos
Autores principales: Godoy, Patricio, Hewitt, Nicola J., Albrecht, Ute, Andersen, Melvin E., Ansari, Nariman, Bhattacharya, Sudin, Bode, Johannes Georg, Bolleyn, Jennifer, Borner, Christoph, Böttger, Jan, Braeuning, Albert, Budinsky, Robert A., Burkhardt, Britta, Cameron, Neil R., Camussi, Giovanni, Cho, Chong-Su, Choi, Yun-Jaie, Craig Rowlands, J., Dahmen, Uta, Damm, Georg, Dirsch, Olaf, Donato, María Teresa, Dong, Jian, Dooley, Steven, Drasdo, Dirk, Eakins, Rowena, Ferreira, Karine Sá, Fonsato, Valentina, Fraczek, Joanna, Gebhardt, Rolf, Gibson, Andrew, Glanemann, Matthias, Goldring, Chris E. P., Gómez-Lechón, María José, Groothuis, Geny M. M., Gustavsson, Lena, Guyot, Christelle, Hallifax, David, Hammad, Seddik, Hayward, Adam, Häussinger, Dieter, Hellerbrand, Claus, Hewitt, Philip, Hoehme, Stefan, Holzhütter, Hermann-Georg, Houston, J. Brian, Hrach, Jens, Ito, Kiyomi, Jaeschke, Hartmut, Keitel, Verena, Kelm, Jens M., Kevin Park, B., Kordes, Claus, Kullak-Ublick, Gerd A., LeCluyse, Edward L., Lu, Peng, Luebke-Wheeler, Jennifer, Lutz, Anna, Maltman, Daniel J., Matz-Soja, Madlen, McMullen, Patrick, Merfort, Irmgard, Messner, Simon, Meyer, Christoph, Mwinyi, Jessica, Naisbitt, Dean J., Nussler, Andreas K., Olinga, Peter, Pampaloni, Francesco, Pi, Jingbo, Pluta, Linda, Przyborski, Stefan A., Ramachandran, Anup, Rogiers, Vera, Rowe, Cliff, Schelcher, Celine, Schmich, Kathrin, Schwarz, Michael, Singh, Bijay, Stelzer, Ernst H. K., Stieger, Bruno, Stöber, Regina, Sugiyama, Yuichi, Tetta, Ciro, Thasler, Wolfgang E., Vanhaecke, Tamara, Vinken, Mathieu, Weiss, Thomas S., Widera, Agata, Woods, Courtney G., Xu, Jinghai James, Yarborough, Kathy M., Hengstler, Jan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753504/
https://www.ncbi.nlm.nih.gov/pubmed/23974980
http://dx.doi.org/10.1007/s00204-013-1078-5
_version_ 1782281843578503168
author Godoy, Patricio
Hewitt, Nicola J.
Albrecht, Ute
Andersen, Melvin E.
Ansari, Nariman
Bhattacharya, Sudin
Bode, Johannes Georg
Bolleyn, Jennifer
Borner, Christoph
Böttger, Jan
Braeuning, Albert
Budinsky, Robert A.
Burkhardt, Britta
Cameron, Neil R.
Camussi, Giovanni
Cho, Chong-Su
Choi, Yun-Jaie
Craig Rowlands, J.
Dahmen, Uta
Damm, Georg
Dirsch, Olaf
Donato, María Teresa
Dong, Jian
Dooley, Steven
Drasdo, Dirk
Eakins, Rowena
Ferreira, Karine Sá
Fonsato, Valentina
Fraczek, Joanna
Gebhardt, Rolf
Gibson, Andrew
Glanemann, Matthias
Goldring, Chris E. P.
Gómez-Lechón, María José
Groothuis, Geny M. M.
Gustavsson, Lena
Guyot, Christelle
Hallifax, David
Hammad, Seddik
Hayward, Adam
Häussinger, Dieter
Hellerbrand, Claus
Hewitt, Philip
Hoehme, Stefan
Holzhütter, Hermann-Georg
Houston, J. Brian
Hrach, Jens
Ito, Kiyomi
Jaeschke, Hartmut
Keitel, Verena
Kelm, Jens M.
Kevin Park, B.
Kordes, Claus
Kullak-Ublick, Gerd A.
LeCluyse, Edward L.
Lu, Peng
Luebke-Wheeler, Jennifer
Lutz, Anna
Maltman, Daniel J.
Matz-Soja, Madlen
McMullen, Patrick
Merfort, Irmgard
Messner, Simon
Meyer, Christoph
Mwinyi, Jessica
Naisbitt, Dean J.
Nussler, Andreas K.
Olinga, Peter
Pampaloni, Francesco
Pi, Jingbo
Pluta, Linda
Przyborski, Stefan A.
Ramachandran, Anup
Rogiers, Vera
Rowe, Cliff
Schelcher, Celine
Schmich, Kathrin
Schwarz, Michael
Singh, Bijay
Stelzer, Ernst H. K.
Stieger, Bruno
Stöber, Regina
Sugiyama, Yuichi
Tetta, Ciro
Thasler, Wolfgang E.
Vanhaecke, Tamara
Vinken, Mathieu
Weiss, Thomas S.
Widera, Agata
Woods, Courtney G.
Xu, Jinghai James
Yarborough, Kathy M.
Hengstler, Jan G.
author_facet Godoy, Patricio
Hewitt, Nicola J.
Albrecht, Ute
Andersen, Melvin E.
Ansari, Nariman
Bhattacharya, Sudin
Bode, Johannes Georg
Bolleyn, Jennifer
Borner, Christoph
Böttger, Jan
Braeuning, Albert
Budinsky, Robert A.
Burkhardt, Britta
Cameron, Neil R.
Camussi, Giovanni
Cho, Chong-Su
Choi, Yun-Jaie
Craig Rowlands, J.
Dahmen, Uta
Damm, Georg
Dirsch, Olaf
Donato, María Teresa
Dong, Jian
Dooley, Steven
Drasdo, Dirk
Eakins, Rowena
Ferreira, Karine Sá
Fonsato, Valentina
Fraczek, Joanna
Gebhardt, Rolf
Gibson, Andrew
Glanemann, Matthias
Goldring, Chris E. P.
Gómez-Lechón, María José
Groothuis, Geny M. M.
Gustavsson, Lena
Guyot, Christelle
Hallifax, David
Hammad, Seddik
Hayward, Adam
Häussinger, Dieter
Hellerbrand, Claus
Hewitt, Philip
Hoehme, Stefan
Holzhütter, Hermann-Georg
Houston, J. Brian
Hrach, Jens
Ito, Kiyomi
Jaeschke, Hartmut
Keitel, Verena
Kelm, Jens M.
Kevin Park, B.
Kordes, Claus
Kullak-Ublick, Gerd A.
LeCluyse, Edward L.
Lu, Peng
Luebke-Wheeler, Jennifer
Lutz, Anna
Maltman, Daniel J.
Matz-Soja, Madlen
McMullen, Patrick
Merfort, Irmgard
Messner, Simon
Meyer, Christoph
Mwinyi, Jessica
Naisbitt, Dean J.
Nussler, Andreas K.
Olinga, Peter
Pampaloni, Francesco
Pi, Jingbo
Pluta, Linda
Przyborski, Stefan A.
Ramachandran, Anup
Rogiers, Vera
Rowe, Cliff
Schelcher, Celine
Schmich, Kathrin
Schwarz, Michael
Singh, Bijay
Stelzer, Ernst H. K.
Stieger, Bruno
Stöber, Regina
Sugiyama, Yuichi
Tetta, Ciro
Thasler, Wolfgang E.
Vanhaecke, Tamara
Vinken, Mathieu
Weiss, Thomas S.
Widera, Agata
Woods, Courtney G.
Xu, Jinghai James
Yarborough, Kathy M.
Hengstler, Jan G.
author_sort Godoy, Patricio
collection PubMed
description This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage. Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4α, FXR, LXR, SHP, VDR and PPAR) and signaling pathways. When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g. HNF-4α), resulting in up- and downregulation of hundreds of genes. An understanding of these changes is crucial for a correct interpretation of in vitro data. The possibilities and limitations of the most useful liver in vitro systems are summarized, including three-dimensional culture techniques, co-cultures with non-parenchymal cells, hepatospheres, precision cut liver slices and the isolated perfused liver. Also discussed is how closely hepatoma, stem cell and iPS cell–derived hepatocyte-like-cells resemble real hepatocytes. Finally, a summary is given of the state of the art of liver in vitro and mathematical modeling systems that are currently used in the pharmaceutical industry with an emphasis on drug metabolism, prediction of clearance, drug interaction, transporter studies and hepatotoxicity. One key message is that despite our enthusiasm for in vitro systems, we must never lose sight of the in vivo situation. Although hepatocytes have been isolated for decades, the hunt for relevant alternative systems has only just begun. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-013-1078-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3753504
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-37535042013-09-04 Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME Godoy, Patricio Hewitt, Nicola J. Albrecht, Ute Andersen, Melvin E. Ansari, Nariman Bhattacharya, Sudin Bode, Johannes Georg Bolleyn, Jennifer Borner, Christoph Böttger, Jan Braeuning, Albert Budinsky, Robert A. Burkhardt, Britta Cameron, Neil R. Camussi, Giovanni Cho, Chong-Su Choi, Yun-Jaie Craig Rowlands, J. Dahmen, Uta Damm, Georg Dirsch, Olaf Donato, María Teresa Dong, Jian Dooley, Steven Drasdo, Dirk Eakins, Rowena Ferreira, Karine Sá Fonsato, Valentina Fraczek, Joanna Gebhardt, Rolf Gibson, Andrew Glanemann, Matthias Goldring, Chris E. P. Gómez-Lechón, María José Groothuis, Geny M. M. Gustavsson, Lena Guyot, Christelle Hallifax, David Hammad, Seddik Hayward, Adam Häussinger, Dieter Hellerbrand, Claus Hewitt, Philip Hoehme, Stefan Holzhütter, Hermann-Georg Houston, J. Brian Hrach, Jens Ito, Kiyomi Jaeschke, Hartmut Keitel, Verena Kelm, Jens M. Kevin Park, B. Kordes, Claus Kullak-Ublick, Gerd A. LeCluyse, Edward L. Lu, Peng Luebke-Wheeler, Jennifer Lutz, Anna Maltman, Daniel J. Matz-Soja, Madlen McMullen, Patrick Merfort, Irmgard Messner, Simon Meyer, Christoph Mwinyi, Jessica Naisbitt, Dean J. Nussler, Andreas K. Olinga, Peter Pampaloni, Francesco Pi, Jingbo Pluta, Linda Przyborski, Stefan A. Ramachandran, Anup Rogiers, Vera Rowe, Cliff Schelcher, Celine Schmich, Kathrin Schwarz, Michael Singh, Bijay Stelzer, Ernst H. K. Stieger, Bruno Stöber, Regina Sugiyama, Yuichi Tetta, Ciro Thasler, Wolfgang E. Vanhaecke, Tamara Vinken, Mathieu Weiss, Thomas S. Widera, Agata Woods, Courtney G. Xu, Jinghai James Yarborough, Kathy M. Hengstler, Jan G. Arch Toxicol Review Article This review encompasses the most important advances in liver functions and hepatotoxicity and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested, zonated lobules, the liver consists of approximately 80 % hepatocytes and 20 % non-parenchymal cells, the latter being involved in a secondary phase that may dramatically aggravate the initial damage. Hepatotoxicity, as well as hepatic metabolism, is controlled by a set of nuclear receptors (including PXR, CAR, HNF-4α, FXR, LXR, SHP, VDR and PPAR) and signaling pathways. When isolating liver cells, some pathways are activated, e.g., the RAS/MEK/ERK pathway, whereas others are silenced (e.g. HNF-4α), resulting in up- and downregulation of hundreds of genes. An understanding of these changes is crucial for a correct interpretation of in vitro data. The possibilities and limitations of the most useful liver in vitro systems are summarized, including three-dimensional culture techniques, co-cultures with non-parenchymal cells, hepatospheres, precision cut liver slices and the isolated perfused liver. Also discussed is how closely hepatoma, stem cell and iPS cell–derived hepatocyte-like-cells resemble real hepatocytes. Finally, a summary is given of the state of the art of liver in vitro and mathematical modeling systems that are currently used in the pharmaceutical industry with an emphasis on drug metabolism, prediction of clearance, drug interaction, transporter studies and hepatotoxicity. One key message is that despite our enthusiasm for in vitro systems, we must never lose sight of the in vivo situation. Although hepatocytes have been isolated for decades, the hunt for relevant alternative systems has only just begun. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-013-1078-5) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2013-08-23 2013 /pmc/articles/PMC3753504/ /pubmed/23974980 http://dx.doi.org/10.1007/s00204-013-1078-5 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Review Article
Godoy, Patricio
Hewitt, Nicola J.
Albrecht, Ute
Andersen, Melvin E.
Ansari, Nariman
Bhattacharya, Sudin
Bode, Johannes Georg
Bolleyn, Jennifer
Borner, Christoph
Böttger, Jan
Braeuning, Albert
Budinsky, Robert A.
Burkhardt, Britta
Cameron, Neil R.
Camussi, Giovanni
Cho, Chong-Su
Choi, Yun-Jaie
Craig Rowlands, J.
Dahmen, Uta
Damm, Georg
Dirsch, Olaf
Donato, María Teresa
Dong, Jian
Dooley, Steven
Drasdo, Dirk
Eakins, Rowena
Ferreira, Karine Sá
Fonsato, Valentina
Fraczek, Joanna
Gebhardt, Rolf
Gibson, Andrew
Glanemann, Matthias
Goldring, Chris E. P.
Gómez-Lechón, María José
Groothuis, Geny M. M.
Gustavsson, Lena
Guyot, Christelle
Hallifax, David
Hammad, Seddik
Hayward, Adam
Häussinger, Dieter
Hellerbrand, Claus
Hewitt, Philip
Hoehme, Stefan
Holzhütter, Hermann-Georg
Houston, J. Brian
Hrach, Jens
Ito, Kiyomi
Jaeschke, Hartmut
Keitel, Verena
Kelm, Jens M.
Kevin Park, B.
Kordes, Claus
Kullak-Ublick, Gerd A.
LeCluyse, Edward L.
Lu, Peng
Luebke-Wheeler, Jennifer
Lutz, Anna
Maltman, Daniel J.
Matz-Soja, Madlen
McMullen, Patrick
Merfort, Irmgard
Messner, Simon
Meyer, Christoph
Mwinyi, Jessica
Naisbitt, Dean J.
Nussler, Andreas K.
Olinga, Peter
Pampaloni, Francesco
Pi, Jingbo
Pluta, Linda
Przyborski, Stefan A.
Ramachandran, Anup
Rogiers, Vera
Rowe, Cliff
Schelcher, Celine
Schmich, Kathrin
Schwarz, Michael
Singh, Bijay
Stelzer, Ernst H. K.
Stieger, Bruno
Stöber, Regina
Sugiyama, Yuichi
Tetta, Ciro
Thasler, Wolfgang E.
Vanhaecke, Tamara
Vinken, Mathieu
Weiss, Thomas S.
Widera, Agata
Woods, Courtney G.
Xu, Jinghai James
Yarborough, Kathy M.
Hengstler, Jan G.
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
title Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
title_full Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
title_fullStr Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
title_full_unstemmed Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
title_short Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
title_sort recent advances in 2d and 3d in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and adme
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753504/
https://www.ncbi.nlm.nih.gov/pubmed/23974980
http://dx.doi.org/10.1007/s00204-013-1078-5
work_keys_str_mv AT godoypatricio recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT hewittnicolaj recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT albrechtute recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT andersenmelvine recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT ansarinariman recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT bhattacharyasudin recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT bodejohannesgeorg recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT bolleynjennifer recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT bornerchristoph recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT bottgerjan recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT braeuningalbert recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT budinskyroberta recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT burkhardtbritta recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT cameronneilr recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT camussigiovanni recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT chochongsu recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT choiyunjaie recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT craigrowlandsj recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT dahmenuta recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT dammgeorg recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT dirscholaf recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT donatomariateresa recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT dongjian recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT dooleysteven recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT drasdodirk recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT eakinsrowena recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT ferreirakarinesa recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT fonsatovalentina recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT fraczekjoanna recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT gebhardtrolf recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT gibsonandrew recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT glanemannmatthias recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT goldringchrisep recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT gomezlechonmariajose recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT groothuisgenymm recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT gustavssonlena recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT guyotchristelle recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT hallifaxdavid recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT hammadseddik recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT haywardadam recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT haussingerdieter recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT hellerbrandclaus recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT hewittphilip recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT hoehmestefan recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT holzhutterhermanngeorg recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT houstonjbrian recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT hrachjens recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT itokiyomi recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT jaeschkehartmut recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT keitelverena recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT kelmjensm recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT kevinparkb recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT kordesclaus recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT kullakublickgerda recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT lecluyseedwardl recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT lupeng recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT luebkewheelerjennifer recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT lutzanna recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT maltmandanielj recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT matzsojamadlen recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT mcmullenpatrick recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT merfortirmgard recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT messnersimon recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT meyerchristoph recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT mwinyijessica recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT naisbittdeanj recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT nusslerandreask recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT olingapeter recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT pampalonifrancesco recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT pijingbo recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT plutalinda recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT przyborskistefana recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT ramachandrananup recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT rogiersvera recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT rowecliff recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT schelcherceline recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT schmichkathrin recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT schwarzmichael recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT singhbijay recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT stelzerernsthk recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT stiegerbruno recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT stoberregina recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT sugiyamayuichi recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT tettaciro recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT thaslerwolfgange recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT vanhaecketamara recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT vinkenmathieu recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT weissthomass recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT wideraagata recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT woodscourtneyg recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT xujinghaijames recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT yarboroughkathym recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme
AT hengstlerjang recentadvancesin2dand3dinvitrosystemsusingprimaryhepatocytesalternativehepatocytesourcesandnonparenchymallivercellsandtheiruseininvestigatingmechanismsofhepatotoxicitycellsignalingandadme